{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:16:40Z","timestamp":1791274600864,"version":"4.1.0"},"reference-count":41,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2017,9,2]],"date-time":"2017-09-02T00:00:00Z","timestamp":1504310400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,9,2]],"date-time":"2017-09-02T00:00:00Z","timestamp":1504310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Invest"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1111\/eci.12798","type":"journal-article","created":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T09:56:42Z","timestamp":1502359002000},"page":"728-735","source":"Crossref","is-referenced-by-count":27,"title":["Complement C3 and fatty liver disease in Rheumatoid arthritis patients: a cross-sectional study"],"prefix":"10.1111","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8194-8642","authenticated-orcid":false,"given":"Francesco","family":"Ursini","sequence":"first","affiliation":[{"name":"Department of Health Sciences; University of Catanzaro \u201cMagna Graecia\u201d; Catanzaro Italy"},{"name":"Rheumatology Department of Lucania; \u201cSan Carlo\u201d Hospital of Potenza and \u201cMadonna delle Grazie\u201d Hospital of Matera; Potenza Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Russo","sequence":"additional","affiliation":[{"name":"Department of Health Sciences; University of Catanzaro \u201cMagna Graecia\u201d; Catanzaro Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Mauro","sequence":"additional","affiliation":[{"name":"Centre for Experimental Medicine & Rheumatology; William Harvey Research Institute - Queen Mary University of London; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovico","family":"Abenavoli","sequence":"additional","affiliation":[{"name":"Department of Health Sciences; University of Catanzaro \u201cMagna Graecia\u201d; Catanzaro Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Ammerata","sequence":"additional","affiliation":[{"name":"Department of Health Sciences; University of Catanzaro \u201cMagna Graecia\u201d; Catanzaro Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Serrao","sequence":"additional","affiliation":[{"name":"\u201dPugliese-Ciaccio\u201d Public Hospital; Catanzaro Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Daniela","family":"Grembiale","sequence":"additional","affiliation":[{"name":"Department of Health Sciences; University of Catanzaro \u201cMagna Graecia\u201d; Catanzaro Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovambattista","family":"De Sarro","sequence":"additional","affiliation":[{"name":"Department of Health Sciences; University of Catanzaro \u201cMagna Graecia\u201d; Catanzaro Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignazio","family":"Olivieri","sequence":"additional","affiliation":[{"name":"Rheumatology Department of Lucania; \u201cSan Carlo\u201d Hospital of Potenza and \u201cMadonna delle Grazie\u201d Hospital of Matera; Potenza Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"D'angelo","sequence":"additional","affiliation":[{"name":"Rheumatology Department of Lucania; \u201cSan Carlo\u201d Hospital of Potenza and \u201cMadonna delle Grazie\u201d Hospital of Matera; Potenza Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,9,2]]},"reference":[{"key":"10.1111\/eci.12798-BIB0001|eci12798-cit-0001","doi-asserted-by":"crossref","first-page":"e0170108","DOI":"10.1371\/journal.pone.0170108","article-title":"Increased cardiovascular events and subclinical atherosclerosis in Rheumatoid arthritis patients: 1 year prospective single centre study","volume":"12","author":"Ruscitti","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1111\/eci.12798-BIB0002|eci12798-cit-0002","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/ard.2010.143396","article-title":"The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: A Danish nationwide cohort study","volume":"70","author":"Lindhardsen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/eci.12798-BIB0003|eci12798-cit-0003","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1186\/ar3442","article-title":"Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study","volume":"13","author":"Innala","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1111\/eci.12798-BIB0004|eci12798-cit-0004","doi-asserted-by":"crossref","first-page":"e2552","DOI":"10.1097\/MD.0000000000002552","article-title":"Prevalence of undiagnosed diabetes in Rheumatoid arthritis: an OGTT study","volume":"95","author":"Ursini","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/eci.12798-BIB0005|eci12798-cit-0005","article-title":"Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the implementation of cardiovascular risk management in Rheumatoid arthritis project","author":"Oever","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/eci.12798-BIB0006|eci12798-cit-0006","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.2009.113696","article-title":"EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis","volume":"69","author":"Peters","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/eci.12798-BIB0007|eci12798-cit-0007","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kex054","article-title":"Cardiovascular risk management in rheumatoid arthritis: challenges ahead: Barriers in the implementation of cardiovascular risk management for rheumatoid arthritis patients in daily practice","author":"Popa","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/eci.12798-BIB0008|eci12798-cit-0008","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"10.1111\/eci.12798-BIB0009|eci12798-cit-0009","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.dld.2017.01.147","article-title":"AISF position paper on nonalcoholic fatty liver disease (NAFLD): updates and future directions","volume":"49","author":"Lonardo","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1111\/eci.12798-BIB0010|eci12798-cit-0010","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11894-009-0008-4","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk","volume":"11","author":"Misra","year":"2009","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1111\/eci.12798-BIB0011|eci12798-cit-0011","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/ard.34.2.198-d","article-title":"Proceedings: liver function tests and liver biopsies in patients with rheumatoid arthritis","volume":"34","author":"Rau","year":"1975","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/eci.12798-BIB0012|eci12798-cit-0012","first-page":"254","article-title":"TNF-alpha and insulin-resistance: metabolic effects of in vivo therapeutic blockade","volume":"61","author":"Ursini","year":"2009","journal-title":"Reumatismo"},{"key":"10.1111\/eci.12798-BIB0013|eci12798-cit-0013","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1586\/1744666X.2016.1168293","article-title":"IL-1beta at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone?","volume":"12","author":"Giacomelli","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1111\/eci.12798-BIB0014|eci12798-cit-0014","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.4103\/0976-500X.120943","article-title":"Abatacept in psoriatic arthritis: case report and short review","volume":"4","author":"Ursini","year":"2013","journal-title":"J Pharmacol Pharmacother"},{"key":"10.1111\/eci.12798-BIB0015|eci12798-cit-0015","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.intimp.2010.04.016","article-title":"Kaposi's sarcoma in a psoriatic arthritis patient treated with infliximab","volume":"10","author":"Ursini","year":"2010","journal-title":"Int Immunopharmacol"},{"key":"10.1111\/eci.12798-BIB0016|eci12798-cit-0016","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jbspin.2016.07.006","article-title":"Retrospective analysis of type 2 diabetes prevalence in a systemic sclerosis cohort from southern Italy: comment on \u201cReduced incidence of Type 1 diabetes and Type 2 diabetes in systemic sclerosis: a nationwide cohort study\u201d by Tseng et al., Joint Bone Spine 2016;83:307-13","volume":"83","author":"Ursini","year":"2016","journal-title":"Joint Bone Spine"},{"key":"10.1111\/eci.12798-BIB0017|eci12798-cit-0017","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/cei.12667","article-title":"Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1beta via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients","volume":"182","author":"Ruscitti","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/eci.12798-BIB0018|eci12798-cit-0018","doi-asserted-by":"crossref","first-page":"782382","DOI":"10.1155\/2015\/782382","article-title":"The role of IL-1beta in the bone loss during rheumatic diseases","volume":"2015","author":"Ruscitti","year":"2015","journal-title":"Mediators Inflamm"},{"key":"10.1111\/eci.12798-BIB0019|eci12798-cit-0019","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/01.hjr.0000244582.30421.b2","article-title":"Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study","volume":"14","author":"Engstrom","year":"2007","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1111\/eci.12798-BIB0020|eci12798-cit-0020","doi-asserted-by":"crossref","first-page":"823763","DOI":"10.1155\/2014\/823763","article-title":"Methotrexate-associated nonalcoholic fatty liver disease with transaminitis in rheumatoid arthritis","volume":"2014","author":"Sakthiswary","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"10.1111\/eci.12798-BIB0021|eci12798-cit-0021","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.dld.2011.08.013","article-title":"Liver stiffness correlates with methotrexate cumulative dose in patients with rheumatoid arthritis","volume":"44","author":"Arena","year":"2012","journal-title":"Dig Liver Dis"},{"key":"10.1111\/eci.12798-BIB0022|eci12798-cit-0022","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/hep.23228","article-title":"Activation of the complement system in human nonalcoholic fatty liver disease","volume":"50","author":"Rensen","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/eci.12798-BIB0023|eci12798-cit-0023","doi-asserted-by":"crossref","first-page":"e110053","DOI":"10.1371\/journal.pone.0110053","article-title":"Complement alternative pathway activation in human nonalcoholic steatohepatitis","volume":"9","author":"Segers","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1111\/eci.12798-BIB0024|eci12798-cit-0024","doi-asserted-by":"crossref","first-page":"e0122026","DOI":"10.1371\/journal.pone.0122026","article-title":"Association between complement C3 and prevalence of fatty liver disease in an adult population: a cross-sectional study from the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIHealth) cohort study","volume":"10","author":"Jia","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1111\/eci.12798-BIB0025|eci12798-cit-0025","doi-asserted-by":"crossref","first-page":"23279","DOI":"10.1038\/srep23279","article-title":"Serum complement C3 levels are associated with nonalcoholic fatty liver disease independently of metabolic features in Chinese population","volume":"6","author":"Xu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1111\/eci.12798-BIB0026|eci12798-cit-0026","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s10067-013-2366-4","article-title":"Serum complement C3 correlates with insulin resistance in never treated psoriatic arthritis patients","volume":"33","author":"Ursini","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1111\/eci.12798-BIB0027|eci12798-cit-0027","doi-asserted-by":"crossref","first-page":"e0163464","DOI":"10.1371\/journal.pone.0163464","article-title":"Complement C3 Is the Strongest Predictor of Whole-Body Insulin Sensitivity in Psoriatic Arthritis","volume":"11","author":"Ursini","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1111\/eci.12798-BIB0028|eci12798-cit-0028","first-page":"18","article-title":"Serum complement C3 strongly correlates with whole-body insulin sensitivity in rheumatoid arthritis","volume":"35","author":"Ursini","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/eci.12798-BIB0029|eci12798-cit-0029","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s10067-012-2034-0","article-title":"Improvement in insulin resistance after short-term treatment with abatacept: case report and short review","volume":"31","author":"Ursini","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1111\/eci.12798-BIB0030|eci12798-cit-0030","doi-asserted-by":"crossref","first-page":"e888","DOI":"10.1097\/MD.0000000000000888","article-title":"Abatacept improves whole-body insulin sensitivity in rheumatoid arthritis: an observational study","volume":"94","author":"Ursini","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/eci.12798-BIB0031|eci12798-cit-0031","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1111\/eci.12798-BIB0032|eci12798-cit-0032","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1111\/eci.12798-BIB0033|eci12798-cit-0033","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.24452","article-title":"Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis","volume":"54","author":"Hernaez","year":"2011","journal-title":"Hepatology"},{"key":"10.1111\/eci.12798-BIB0034|eci12798-cit-0034","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1111\/eci.12798-BIB0035|eci12798-cit-0035","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"10.1111\/eci.12798-BIB0036|eci12798-cit-0036","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/rheumatology\/kep252","article-title":"Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies","volume":"48","author":"Meune","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/eci.12798-BIB0037|eci12798-cit-0037","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/toxsci\/kfu156","article-title":"Increased susceptibility to methotrexate-induced toxicity in nonalcoholic steatohepatitis","volume":"142","author":"Hardwick","year":"2014","journal-title":"Toxicol Sci"},{"key":"10.1111\/eci.12798-BIB0038|eci12798-cit-0038","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/eci.12093","article-title":"Activated complement factor 3 is associated with liver fat and liver enzymes: the CODAM study","volume":"43","author":"Wlazlo","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/eci.12798-BIB0039|eci12798-cit-0039","doi-asserted-by":"crossref","first-page":"e108132","DOI":"10.1371\/journal.pone.0108132","article-title":"Serum complement C3f and fibrinopeptide A are potential novel diagnostic biomarkers for non-alcoholic fatty liver disease: a study in Qingdao Twins","volume":"9","author":"Xin","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1111\/eci.12798-BIB0040|eci12798-cit-0040","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/07853890701477546","article-title":"Rheumatoid arthritis and the complement system","volume":"39","author":"Okroj","year":"2007","journal-title":"Ann Med"},{"key":"10.1111\/eci.12798-BIB0041|eci12798-cit-0041","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study","volume":"42","author":"Bedogni","year":"2005","journal-title":"Hepatology"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Feci.12798","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/eci.12798\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T00:22:49Z","timestamp":1625358169000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/eci.12798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,2]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"URL":"https:\/\/doi.org\/10.1111\/eci.12798","archive":["Portico"],"relation":{},"ISSN":["0014-2972"],"issn-type":[{"value":"0014-2972","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9,2]]}}}